WASHINGTON — The Consumer Healthcare Products Association board of directors on Friday approved voluntary labeling guidelines for caffeine-containing dietary supplements discussed during the June 18 board meeting. The voluntary measure was taken in support of the Food and Drug Administration’s suggestion to food and dietary supplement manufacturers to include more information about caffeine on product labels.
“Over-the-counter medicines containing caffeine disclose its presence on the label with the amount in each dose, in addition to including important cautionary statements," stated Barbara Kochanowski, VP of regulatory and scientific affairs at CHPA. "These new guidelines will ensure equal transparency for our members’ dietary supplements, giving consumers the information they need to safely choose and use a dietary supplement."
CHPA members marketing caffeine-containing dietary supplements agree to adopt voluntary guidelines addressing labeling, packaging and promotion to ensure safe and responsible use of these products.
The guidelines include the following:
- Provide disclosure of total caffeine content (mg/serving);
- Provide information that should be included in labeling for a supplement containing more than 100 mg per serving (i.e., not intended for children less than 18 years of age or for caffeine-sensitive individuals, and pregnant or nursing women should talk to a healthcare professional before use); and
- Stipulate that caffeine-containing supplements should not be marketed, advertised or promoted in combination with alcohol.
A full description of the guidelines can be viewed here.